BioLargo reaffirms commitment to protecting proprietary technology

BioLargo (BLGO) reaffirmed its commitment to protecting the proprietary technology that built the Pooph pet-products brand and to defending its intellectual property, stockholders, and reputation following recent public statements by Pooph, Inc. The company said, “On September 25, 2025, BioLargo revoked Pooph’s license to manufacture, market, and sell products containing BioLargo’s technology after Pooph’s failure to pay approximately $3.8 million owed for product purchases and license royalties, and the marketing of its products outside the pet industry. This termination followed on BioLargo’s prior notice to Pooph that it had ceased delivering products due to Pooph’s failure to pay monies owed. Despite BioLargo’s clear and lawful termination of the license, Pooph issued a press release containing allegations that BioLargo strongly denies and will vigorously defend against. The press release further referenced a lawsuit Pooph claims to have filed but has not yet attempted legal service. BioLargo emphasizes that its focus now is on protecting its intellectual property and redeploying its technology with new partners that share its commitment to quality, transparency, and integrity.”